FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.

doi:10.1093/cid/ciac433

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 8 Feb 2023

Vink Frederique J, Meijer Chris J L M, Hesselink Albertus T, Floore Arno N, Lissenberg-Witte Birgit I, Bonde Jesper H, Pedersen Helle, Cuschieri Kate, Bhatia Ramya, Poljak Mario, Oštrbenk Valenčak Anja, Hillemanns Peter, Quint Wim G V, Del Pino Marta, Kenter Gemma G, Steenbergen Renske D M, Heideman Daniëlle A M, Bleeker Maaike C G

Abstract excerpt

BACKGROUND: High-grade squamous intraepithelial lesions (HSIL) or cervical intraepithelial neoplasia (CIN) grade 2/3 lesions in human papillomavirus (HPV)-positive women <30 years of age have high spontaneous regression rates. To reduce overtreatment, biomarkers are needed to delineate advanced CIN lesions that require treatment. We analyzed the FAM19A4/miR124-2 methylation test and HPV16/18 genotyping in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Human papillomavirus 16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human papillomavirus 18

Share to Human Papillomavirus Viruses

Share to Ki-67 Antigen

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35686306
DOI: 10.1093/cid/ciac433
PMCID: PMC9907535

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.PMID 35686306Read ↗

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.Semantic proximity Read ↗

Tissue-based methylation testing as a predictor of clinical regression in patients with high- grade cervical intraepithelial neoplasia (CIN2/3)Semantic proximity Read ↗

FAM19A4 and hsa-miR124-2 Double Methylation as Screening for ASC-H- and CIN1 HPV-Positive WomenSemantic proximity Read ↗

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide studySemantic proximity Read ↗

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.Semantic proximity Read ↗

Cervix cytology samples revealed increased methylation of the human markers FAM19A4 / miR124‐2 up to 8 years before adenocarcinomaSemantic proximity Read ↗

Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden.Semantic proximity Read ↗

Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.Semantic proximity Read ↗

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.Semantic proximity Read ↗

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.Semantic proximity Read ↗

Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study).Semantic proximity Read ↗

Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.